Sign Up | Feedback | Log In

Neurontin

/ 13 Views

Teva Announces Appeals Court Ruling Affirming Invalidation of Yasmin Patent

Aug 5, 2009 2:23 PM

Excerpt This release contains forward-looking statements, which express the current beliefs and expectations of management. Such statements are based on management's current beliefs and expecta...

Identifying the Side Effects Associated with Neurontin

Aug 5, 2009 1:51 PM

Excerpt If you have been prescribed Neurontin, it is important that you learn how to identify the side effects associated with this medication. This prescription drug is considered to be an ant...

Neurontin case dropped after mystery donation

Jul 30, 2009 7:14 AM

Excerpt Mystery donor to the rescue. The first Neurontin trial is kaput, thanks to some secret moneybags who set up a trust for the daughter of suicide victim Susan Bulger. The Bulger family's ...

Pfizer - Neurontin: Lanier vs Kindler

Jul 30, 2009 12:41 AM

Excerpt Pfizer Inc. won’t face a verdict over claims its epilepsy drug Neurontin helped lead a Massachusetts woman to commit suicide, after her family dropped its lawsuit in the midst of trial....

Anonymous Donation Brings 'Near-Impossible' Neurontin Test Case to Sudden End

Jul 29, 2009 8:56 PM

Excerpt Earlier this week, we told you about Mark Lanier's admittedly long-shot attempt to win the first trial of the 1,200 suits claiming that Pfizer's epilepsy drug Neurontin increases suicid...

Trial over Pfizer drug ends with mystery donation

Jul 29, 2009 8:38 PM

Excerpt The first personal injury trial over a Pfizer Inc. drug linked to suicide ended abruptly Wednesday when the victim's family accepted $50,000 from an anonymous donor to drop the case. ...

Family drops Neurontin suit against Pfizer

Jul 29, 2009 12:06 PM

Excerpt Pfizer's first trial regarding the epilepsy drug Neurontin is officially over--after just one day of testimony. The lawsuit was brought by the family of Susan Bulger, a Massachusetts wo...

Neurontin witness talks off-label

Jul 29, 2009 7:28 AM

Excerpt The first Neurontin trial is shaping up to be an off-label marketing trial. "The company made a conscious decision to do something illegal--marketing this drug off-label," plaintiffs' l...